vimarsana.com

Page 64 - நரம்பியல் அறுவை சிகிச்சை சிகிச்சையகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Blood-clotting protein linked with tumor pathogenesis of CNS B-cell lymphoma

Blood-clotting protein linked with tumor pathogenesis of CNS B-cell lymphoma In people with central nervous system (CNS) lymphoma, cancerous B cells a type of white blood cell accumulate to form tumors in the brain or spinal cord, often in close proximity to blood vessels. This disease is quite rare, but individuals who are affected have limited treatment options and often experience recurrence. Previous research has linked the severity of CNS lymphoma to abnormal leaks in the blood-brain barrier, a protective system that allows some substances to pass from the bloodstream to the brain, while blocking others. However, the specific molecular details of this link have been murky.

Mental illness in early life linked with poorer health and advanced aging in adulthood

A new pair of studies from a Duke research team's long-term work in New Zealand make the case that mental health struggles in early life can lead to poorer physical health and advanced aging in adulthood.

Study: Cognitive SuperAgers resist protein tangles that lead to Alzheimer s disease

BIAL Takes the Lead in Europe for the Commercialisation of Epilepsy Treatment, Zebinix (eslicarbazepine acetate), Expanding Neurology Footprint

(2) Press Release for European Medical and Trade Media Only BIAL announces the end of the licence agreement established in 2009. BIAL takes the lead for the marketing and distribution of Zebinix (eslicarbazepine acetate) in Europe. Eslicarbazepine acetate is a once-daily anti-epileptic used to treat epilepsy patients with focal seizures (partial-onset seizures) For over a decade, BIAL and Eisai have had an agreement in place for Eisai to market, promote, and distribute eslicarbazepine acetate in Europe. Following the end of this partnership, BIAL will take the lead for the ongoing marketing, promotion and distribution in Europe. This move reinforces its continued commitment to and ongoing investment in neurological conditions.

Irregular sleep schedules connected to bad moods and depression, study shows

 E-Mail An irregular sleep schedule can increase a person s risk of depression over the long term as much as getting fewer hours of sleep overall, or staying up late most nights, a new study suggests. Even when it comes to just their mood the next day, people whose waking time varies from day to day may find themselves in as much of a foul mood as those who stayed up extra late the night before, or got up extra early that morning, the study shows. The study, conducted by a team from Michigan Medicine, the University of Michigan s academic medical center, uses data from direct measurements of the sleep and mood of more than 2,100 early-career physicians over one year. It s published in

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.